FoundMyFitness · 2023-11-09 · Rhonda Patrick
How Vitamin D, Omega-3s, & Exercise May Increase Longevity | Dr. Rhonda Patrick
43 research-tied claims examined: 2 contradicted 4 overstated 3 context 31 supported 3 unverified
4 Overstated
Observational studies show that individuals with the highest magnesium levels have a 40% lower all-cause mortality and a 50% lower cancer mortality compared to those with the lowest levels.
"people with the highest magnesium levels have a 40% lower all-cause mortality and a 50% lower cancer mortality compared to people with the lowest magnesium levels." (said at 0:10:53)
The claim overstates the magnitude of mortality reduction associated with higher serum magnesium levels and asserts a large reduction in cancer mortality that prospective observational evidence does not support. In a prospective cohort study of U.S. adults (NHANES I Epidemiologic Follow-up Study), individuals with very low serum magnesium (<0.7 mmol/L) had a 34% increased risk of all-cause mortality compared to the reference group (HR 1.34, 95% CI: 1.02–1.77), whereas individuals in the highest serum magnesium category (≥1.0 mmol/L) showed no significant reduction in all-cause mortality (HR 0.98, 95% CI: 0.76–1.26). Furthermore, low serum magnesium was not significantly associated with cancer mortality (HR 1.39, 95% CI: 0.83–2.32), contradicting the claimed 50% reduction in cancer mortality.
- contradicts: Serum magnesium concentrations and all-cause, cardiovascular, and cancer mortality among U… (Clinical nutrition (Edinburgh, Scotland) 2018) · cited 36x in the literature
"The multivariate-adjusted HRs (95% CIs) of all-cause mortality across increasing categories of Mg were 1.34 (1.02, 1.77), 0.94 (0.75, 1.18), 1.08 (0.97, 1.19), 1.00 (referent), 1.05 (0.95, 1.16), 0.96 (0.79, 1.15), and 0.98 (0.76, 1.26). Similar trends were observed for cancer (HRs for serum Mg < 0.7: 1.39, 95% CI: 0.83, 2.32) and CVD mortality (HRs for serum Mg < 0.7: 1.28, 95% CI: 0.81, 2.02) but were not statistically significant." (abstract, results, passage verified)
pubmedfull study (doi)
A 2015 study in the American Journal of Pediatrics showed that omega-3 fatty acids consumed by pregnant women eating fish protected against neurotoxicity, resulting in better neural outcomes in children compared to women who avoided fish.
"One, I think big one, was in 2015, American Journal of Pediatrics published that basically the omega-3 fatty acids—women eating fish, the omega-3 fatty acids protected against any neurotoxicity, and in fact, those children had better neural outcomes than women that avoided fish." (said at 0:32:32)
The speaker appears to refer to a 2015 study from the Seychelles Child Development Study Nutrition Cohort 2, published in The American Journal of Clinical Nutrition (not the American Journal of Pediatrics). The observational cohort study evaluated 1,265 mother-child pairs in a high-fish-eating population. It found that maternal polyunsaturated fatty acid (PUFA) profile modified the relationship between prenatal methylmercury exposure and motor development at 20 months: higher n-3 PUFAs attenuated negative associations of mercury on the Psychomotor Developmental Index (PDI). However, the claim is overstated: the study was observational in a cohort where almost all mothers ate ocean fish (it did not compare outcomes against fish-avoiding women), it did not demonstrate protection against 'any neurotoxicity', and higher maternal DHA was paradoxically associated with lower Mental Development Index (MDI) scores alongside positive language development scores.
Exercise generates circulatory shear force that kills circulating tumor cells due to mechanoreceptors on their cell surface.
"Well, exercise itself, there's something called shear force. The shear force of blood flow going through the circulatory system itself kills these circulating tumor cells, and it does it because these tumor cells have these mechanoreceptors on their cell surface, and they're so sensitive to, like, movement." (said at 0:53:34)
While in vitro mechanobiological models demonstrate that fluid shear stresses representative of intense exercise can damage and kill circulating tumor cells (CTCs) via necrosis and apoptosis, this phenomenon is established primarily in microfluidic and cell-culture systems rather than directly verified as an in vivo tumor clearance mechanism in exercising human patients. Extrapolating these in vitro bioengineering findings to state definitively that exercise directly destroys CTCs in the human circulatory system via cell-surface mechanoreceptors overstates the current level of evidence.
In patients diagnosed with colon or breast cancer, engaging in aerobic exercise reduces circulating tumor cells, cancer recurrence (by up to 40%), and cancer mortality.
"And so there's been studies showing that the people that have been diagnosed with either colon cancer or breast cancer, when they engage in physical activity, aerobic exercise, their circulating tumor cells drop down, they're less likely to have cancer recurrence—I mean, dramatically in some cases, you're talking like 40%—and they're less likely to die from their cancer." (said at 0:54:05)
Observational meta-analyses show that postdiagnosis physical activity is associated with an approximately 38% to 42% lower risk of cancer-specific mortality and up to a 40% to 48% reduction in all-cause mortality among breast and colorectal cancer survivors. However, the claim overstates the evidence in two key ways: first, the evidence for recurrence reduction is weaker and often not statistically significant in comprehensive meta-analyses (e.g., HR 0.97, 95% CI 0.91–1.05 in the CUP Global meta-analysis). Second, the evidence that exercise reduces circulating tumor cells (CTCs) comes from small pilot trials (n=23), while a subsequent randomized controlled trial (n=60) found no statistically significant difference in CTC clearance compared to control.
- supports: Effects of exercise on circulating tumor cells among patients with resected stage I-III co… (PloS one 2018) · cited 47x in the literature
"Over six months, significant decreases in CTCs were observed in the low-dose (-1.34±0.34; P<0.001) and high-dose (-1.18±0.40; P = 0.004) exercise groups, whereas no significant change was observed in the control group (-0.59±0.56; P = 0.292)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Physical activity in breast cancer survivors: A systematic review and meta-analysis on ove… (Breast (Edinburgh, Scotland) 2019) · cited 240x in the literature
"Compared to women in the lowest recreational PA level (lowest quintile/quartile), women in the highest level had a lower risk of all-cause mortality (HR = 0.58, 95% CIs: 0.45-0.75; 8 studies), of death from breast cancer (HR = 0.60, 95% CIs 0.36-0.99; 5 studies) and a lower, albeit non-significant, risk of recurrence (HR = 0.79, 95% CIs 0.60-1.05; 5 studies)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Postdiagnosis recreational physical activity and breast cancer prognosis: Global Cancer Up… (International journal of cancer 2023) · cited 63x in the literature
"Nonlinear dose-response meta-analyses indicated 48% lower all-cause and 38% lower breast cancer-specific mortality with increasing recreational physical activity up to 20 MET-h/week, but little further reduction in risk at higher levels. Predefined subgroup analyses across strata of body mass index, hormone receptors, adjustment for confounders, number of deaths, menopause and physical activity intensities were consistent in direction and magnitude to the main analyses. Considering the methodological limitations of the included studies, the independent Expert Panel concluded 'limited-suggestive' likelihood of causality for an association between recreational physical activity and lower risk of all-cause and breast cancer-specific mortality." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in… (Journal of sport and health science 2025) · cited 10x in the literature
"Exercise did not change CTCs (0.59 cells/mL, 95%CI: -0.33 to 1.51; p = 0.21) or tumor fraction (0.0005, 95%CI: -0.0024 to 0.0034; p = 0.73)." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.